Stock Market Reviews

LIVN (LivaNova PLC) News

Get the latest news, insights, and market updates on LIVN (LivaNova PLC). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• LivaNova: Q3 Earnings Snapshot
  LONDON (AP) — LivaNova PLC (LIVN) on Wednesday reported net income of $26.8 million in its third quarter. On a per-share basis, the London-based company said it had net income of 49 cents. Earnings, adjusted for one-time gains and costs, were $1.11 per share.
  Nov 5, 2025 - $LIVN
• LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates
  LivaNova (LIVN) delivered earnings and revenue surprises of +21.98% and +3.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 5, 2025 - $LIVN
• LivaNova (LIVN): Evaluating Undervaluation After Recent Share Price Dip
  LivaNova (LIVN) has seen its stock price dip slightly over the past week, with shares recently closing at $52.63. Its recent performance has caught the attention of investors, particularly in light of year-to-date gains and ongoing sector developments. See our latest analysis for LivaNova. LivaNova’s share price has climbed 12.8% year-to-date, supported by a strong 23.5% gain over the past 90 days. However, momentum cooled this week with a modest dip. Looking at total shareholder return, the...
  Nov 3, 2025 - $LIVN
• Is LivaNova (LIVN) Stock Undervalued Right Now?
  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
  Oct 31, 2025 - $LIVN
• LivaNova to Present at Wolfe Research Healthcare Conference in November
  LONDON, October 23, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Wolfe Research Healthcare Conference 2025 in New York City. The presentation will take place Mon., Nov. 17, at 2:40 p.m. Eastern Standard Time.
  Oct 23, 2025 - $LIVN
• LivaNova to Announce Third-Quarter 2025 Results
  LONDON, October 08, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its third-quarter 2025 results prior to the call.
  Oct 8, 2025 - $LIVN
• LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
  LONDON, October 07, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS) 2025 Annual Meeting in Indianapolis. The Company will present a five-year analysis of the THN-3 randomized control trial (RCT), which studied the use of its aura6000™ System for the treatment of moderate to severe obstructive sleep apnea (OSA). LivaNova will also deliver an oral presentation and feature a scientif
  Oct 7, 2025 - $LIVN
• Assessing LivaNova (LIVN) Valuation After Recent Share Price Swings and Renewed Investor Optimism
  LivaNova (LIVN) recently caught investor attention following its latest movement in the healthcare sector. Shares have seen swings over the past month, making valuation a point of interest for those watching medical device stocks. See our latest analysis for LivaNova. LivaNova’s share price has built momentum over the past several months, and investor confidence now seems steadier as the company’s 1-year total shareholder return edges positive. Recent price swings reflect a broader sense of...
  Oct 6, 2025 - $LIVN
• Apple initiated, DraftKings downgraded: Wall Street's top analyst calls
  Apple initiated, DraftKings downgraded: Wall Street's top analyst calls
  Oct 1, 2025 - $LIVN
• Should Value Investors Buy LivaNova (LIVN) Stock?
  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
  Sep 30, 2025 - $LIVN